Targeted binding agents directed to PDGFR-alpha and uses thereof

Details for Australian Patent Application No. 2007348940 (hide)

Owner AstraZeneca AB

Inventors Kang, Jaspal Singh; Blakey, David Charles; Cartilage, Susan Ann; GazitBornstein, Gadi; Laing, Naomi; Yang, Xiadong; Foltz, Ian; Taylor, Laura

Agent Davies Collison Cave

Pub. Number AU-B-2007348940

PCT Pub. Number WO2008/112003

Priority 60/835,647 03.08.06 US

Filing date 2 August 2007

Wipo publication date 18 September 2008

Acceptance publication date 28 June 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/112003 Priority application(s): WO2008/112003

28 June 2012 Application Accepted

  Published as AU-B-2007348940

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007348941-Antibodies directed to alphaVbeta6 and uses thereof

2007348932-Oriented polymeric sheets exhibiting dichroism and articles containing the same